TORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the market for electrophysiology (EP) mapping and ablation ...

Please provide your email address to receive an email when new articles are posted on . Acutus Medical announced that a second generation of its mapping system for electrophysiology procedures ...

DUBLIN--(BUSINESS WIRE)--The "Cardiac Electrophysiology Mapping, Navigation and Recording Devices Global Market - Forecast to 2024" report has been added to ResearchAndMarkets.com's offering. The ...

- EnSite™ X EP System with EnSite Omnipolar Technology (OT) provides a 360-degree view of the heart, regardless of catheter orientation, for cardiac mapping without compromise ABBOTT PARK, Ill., Jan.

Stereotaxis has announced the submission of the MAGiC Sweep™ catheter for FDA approval, marking the first high-density electrophysiological (EP) mapping catheter designed for robotic navigation using ...

First-of-its-kind, all-in-one HD-mapping and dual energy (pulsed field and radiofrequency) ablation catheter Highly anticipated by electrophysiologists for its innovation and demonstrated safety and ...

Abbott announced it has received CE Mark and approval in Australia for its new EnSite X EP System, and is launching the system throughout Europe and Australia. The EnSite X System is the only system ...

Los Angeles, July 31, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM) (“BioSig” or “Company”), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac ...